Checkpoint Surgical, Inc., a Cleveland, Ohio-based medical device company with proprietary neurostimulation technology for nerve protection and repair, completed an $8.8 preferred funding round.
The round was led by Mutual Capital Partners, with participation from existing backers First Analysis, the JumpStart NEXT Fund, and several individual investors.
The company intends to use the funds to expand its sales and marketing resources, advance new product/market opportunities in nerve regeneration and neuroma pain, as well as bolster its executive team.
Led by President & CEO Len Cosentino, Derek Lewis, new head of operations, research and development, and Rick DiBlasi, new Vice President of Sales, Checkpoint Surgical is medical device company committed to providing surgeons with devices to protect and repair nerve intraoperatively across the anatomy.
FinSMEs
28/09/2018